KYBELLA™ Treatment For Double Chin in Tacoma, WA
Now there is a treatment for your double chin! The FDA has approved KYBELLATM(deoxycholic acid) injection, which contours and improves the appearance of moderate to severe submental fullness due to submental fat. Submental fullness, also known as “double chin,” can affect adult women and men of all ages and weights, and is influenced by multiple factors, including aging and genetics. Submental fullness is often resistant to diet and exercise, and according to a 2014 survey conducted by the American Society for Dermatologic Surgery, 68 percent of people said they are bothered by their double chin.
KYBELLA™ is a formulation of a naturally occurring-substance (deoxycholic acid) that targets and destroys fat cells in the area where it’s injected. Once those cells are destroyed, they can no longer store or accumulate fat. Once the aesthetic response is achieved with KYBELLA™, re-treatment is not expected to be required.
Are There Any side Effects?
Downtime for our patients in Charlotte is minimal for most patients and occurs most commonly after the first treatment. When scheduling your treatment, keep your social plans and work commitments in mind. As with other injectable treatments, the most common side effects are swelling, bruising, pain, numbness, redness and areas of hardness in the treatment area.
How long does KYBELLA™ last?
Once the proper correction is achieved, the treated fat cells are gone forever. In most cases, no additional treatment is needed.
Who is the Best Candidate for KYBELLA™?
Improvement can be seen in virtually every person who has submental fullness. The ideal candidate is someone with moderate fullness and enough skin elasticity to recover after the fat disappears.
Is there downtime with KYBELLA™?
Downtime for our patients in Charlotte is minimal for most patients and occurs most commonly after the first treatment. When scheduling your treatment, keep your social plans and work commitments in mind. As with other injectable treatments, the most common side effects are Swelling, Bruising, pain, numbness, redness and areas of hardness in the treatment area.
KYBELLA® (deoxycholic acid) injection 10 mg/mL Important Information
KYBELLA® (deoxycholic acid) injection is indicated for improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults.
The safe and effective use of KYBELLA® for the treatment of subcutaneous fat outside the submental region has not been established and is not recommended.
IMPORTANT SAFETY INFORMATION
KYBELLA® is contraindicated in the presence of infection at the injection sites.
WARNINGS AND PRECAUTIONS
Marginal Mandibular Nerve Injury
Cases of marginal mandibular nerve injury, manifested as an asymmetric smile or facial muscle weakness, were reported in 4% of subjects in the clinical trials; all cases resolved spontaneously (range 1-298 days, median 44 days). KYBELLA® should not be injected into or in close proximity to the marginal mandibular branch of the facial nerve.
Dysphagia occurred in 2% of subjects in the clinical trials in the setting of administration-site reactions, eg, pain, swelling, and induration of the submental area; all cases of dysphagia resolved spontaneously (range 1-81 days, median 3 days). Avoid use of KYBELLA® in patients with current or prior history of dysphagia as treatment may exacerbate the condition.
In clinical trials, 72% of subjects treated with KYBELLA® experienced hematoma/bruising. KYBELLA® should be used with caution in patients with bleeding abnormalities or who are currently being treated with antiplatelet or anticoagulant therapy as excessive bleeding or bruising in the treatment area may occur.
Risk of Injecting Into or in Proximity to Vulnerable Anatomic Structures
To avoid the potential of tissue damage, KYBELLA® should not be injected into or in close proximity (1 cm-1.5 cm) to salivary glands, lymph nodes, and muscles.
The most commonly reported adverse reactions in the pivotal clinical trials were: injection site edema/swelling, hematoma/bruising, pain, numbness, erythema, and induration.
Please see KYBELLA® full Prescribing Information.